Aveanna Healthcare vs Chemed
Chemed reported revenue of $2.5 billion in fiscal 2025, about the same as Aveanna Healthcare's $2.4 billion in fiscal 2025. Aveanna Healthcare's revenue grew 20.2% in its latest year, and Chemed's grew 4.1%. Aveanna Healthcare had an operating margin of 10.5%, against 13.4% at Chemed. Their fiscal years end in different months (January 3 and December 31), so the periods don't line up exactly.
Side by side
| Aveanna Healthcare | Chemed | |
|---|---|---|
| Latest fiscal year | FY2025, Jan 3, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $2.4B | $2.5B |
| Revenue growth | 20.2% | 4.1% |
| Revenue growth a year, last 5 years | 10.2% | 4.0% |
| Gross margin | 33.3% | 32.5% |
| Operating margin | 10.5% | 13.4% |
| Net margin | 9.2% | 10.5% |
| Free cash flow | — | $325M |
| Free cash flow margin | — | 12.9% |
| Return on capital | 21.6% | 27.3% |
| Net debt to EBITDA | 4.1x | −0.2x |
| Dividends and buybacks | $0M | $463M |
| Change in diluted share count | 11.4% | −4.8% |
| Last close | $11.50 | $548.20 |
| P/E at the last close | 8.2× | 26.3× |
| Insider trades, last 12 months | — | sold $10.9 million |
| Piotroski F-score | 7 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Aveanna HealthcareChemed
Operating margin
Percent of revenue
Aveanna HealthcareChemed
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Aveanna HealthcareChemed
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Aveanna Healthcare and Chemed pages.